Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
14.98
-0.30 (-1.96%)
At close: Dec 19, 2025, 4:00 PM EST
14.92
-0.06 (-0.40%)
After-hours: Dec 19, 2025, 7:54 PM EST
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $135.52 million as of December 19, 2025. Its market cap has decreased by -3.06% in one year.
Market Cap
135.52M
Enterprise Value
173.13M
1-Year Change
-3.06%
Ranking
Category
Stock Price
$14.98
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $135.52M, a decrease of -92.81%. That is a compound annual growth rate of -22.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 135.50M | -4.51% |
| Dec 31, 2024 | 141.90M | -21.60% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
| Jun 26, 2015 | 1.88B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |